FORMULIERUNG EINES NEUARTIGEN BISPEZIFISCHEN ANTI-CD3/CD20-POLYPEPTIDKOMPLEXES
European patent · EP4190352 · In force
Register entry
- Publication number
- EP4190352
- Application number
- EP21849910
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Jul 26, 2021
- Published
- Jun 7, 2023
- Granted
- Mar 25, 2026
- Protection ends at the latest
- Jul 25, 2041
- Next annual fee due
- Jul 31, 2026
- IPC classes
- A61K 9/00 (2006.01)A61K 39/395 (2006.01)A61P 35/00 (2006.01)A61K 9/08 (2006.01)A61K 9/19 (2006.01)A61K 47/12 (2006.01)A61K 47/18 (2017.01)A61K 39/00 (2006.01)C07K 16/28 (2006.01)
- Priority
- CN 202010733597 27.07.2020
- PCT application
- PCT/CN2021/108455 26.07.2021
- PCT publication
- WO2022/022464 03.02.2022
- Filing language
- Chinese
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Mar 25, 2026
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 25.03.2026
Parties
Inventor
ZHU, Youwei
Lianyungang, Jiangsu 222062, CN
LI, Yingchun
Lianyungang, Jiangsu 222062, CN
CHENG, Yanju
Lianyungang, Jiangsu 222062, CN
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.